Sanofi and Merk in $4b Merial sale


Merck is selling the stake because regulators have said its purchase of Schering-Plough would make it too dominant in the animal health market. Sanofi said the price valued Merial at 10 times last year’s earnings and 3 times sales. Merck said that deal was subject to approval by antitrust regulators, but that it expected the transaction to be completed before its takeover of Schering-Plough in the fourth quarter of this year.

Liked the story?

  • 0

    Happy
  • 0

    Amused
  • 0

    Sad
  • 0

    Frustrated
  • 0

    Angry